Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
When radioactive water was a gleam of hope for the sickCarlén-Nilsson, CLäkartidningen, 1999-10, Vol.96 (43), p.4703-4703 [Periódico revisado por pares]SwedenTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trialHoskin, Peter, Prof ; Sartor, Oliver, Prof ; O'Sullivan, Joe M, Prof ; Johannessen, Dag Clement, MD ; Helle, Svein I, MD ; Logue, John, FRCR ; Bottomley, David, FRCR ; Nilsson, Sten, Prof ; Vogelzang, Nicholas J, Prof ; Fang, Fang, PhD ; Wahba, Mona, MD ; Aksnes, Anne-Kirsti, PhD ; Parker, Christopher, MDThe lancet oncology, 2014-11, Vol.15 (12), p.1397-1406 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse ModelsSuominen, Mari I ; Fagerlund, Katja M ; Rissanen, Jukka P ; Konkol, Yvonne M ; Morko, Jukka P ; Peng, ZhiQi ; Alhoniemi, Esa J ; Laine, Salla K ; Corey, Eva ; Mumberg, Dominik ; Ziegelbauer, Karl ; Käkönen, Sanna-Maria ; Halleen, Jussi M ; Vessella, Robert L ; Scholz, ArneClinical cancer research, 2017-08, Vol.23 (15), p.4335-4346 [Periódico revisado por pares]United States: American Association for Cancer Research IncTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA studyNilsson, S. ; Cislo, P. ; Sartor, O. ; Vogelzang, N.J. ; Coleman, R.E. ; O'Sullivan, J.M. ; Reuning-Scherer, J. ; Shan, M. ; Zhan, L. ; Parker, C.Annals of oncology, 2016-05, Vol.27 (5), p.868-874 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access ProgramSartor, Oliver ; Vogelzang, Nicholas J. ; Sweeney, Christopher ; Fernandez, Daniel C. ; Almeida, Fabio ; Iagaru, Andrei ; Brown, Alan ; Smith, Matthew R. ; Agrawal, Manish ; Dicker, Adam P. ; Garcia, Jorge A. ; Lutzky, Jose ; Wong, Yu‐Ning ; Petrenciuc, Oana ; Gratt, Jeremy ; Shore, Neal D. ; Morris, Michael J.The oncologist (Dayton, Ohio), 2018-02, Vol.23 (2), p.193-202 [Periódico revisado por pares]United States: AlphaMed PressTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Whole-Body and Microenvironmental Localization of Radium-223 in Naïve and Mouse Models of Prostate Cancer MetastasisAbou, Diane S ; Ulmert, David ; Doucet, Michele ; Hobbs, Robert F ; Riddle, Ryan C ; Thorek, Daniel L JJNCI : Journal of the National Cancer Institute, 2016-05, Vol.108 (5), p.djv380 [Periódico revisado por pares]United States: Oxford University PressTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
A Randomized, Double-Blind, Dose-Finding, Multicenter, Phase 2 Study of Radium Chloride (Ra 223) in Patients with Bone Metastases and Castration-Resistant Prostate CancerParker, Christopher C ; Pascoe, Sarah ; Chodacki, Aleš ; O'Sullivan, Joe M ; Germá, Josep R ; O’Bryan-Tear, Charles Gillies ; Haider, Trond ; Hoskin, PeterEuropean urology, 2013-02, Vol.63 (2), p.189-197 [Periódico revisado por pares]Kidlington: Elsevier B.VTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA TrialParker, Christopher ; Finkelstein, Steven E ; Michalski, Jeff M ; O'Sullivan, Joe M ; Bruland, Øyvind ; Vogelzang, Nicholas J ; Coleman, Robert E ; Nilsson, Sten ; Sartor, Oliver ; Li, Rui ; Seger, Monica A ; Bottomley, DavidEuropean urology, 2016-11, Vol.70 (5), p.875-883 [Periódico revisado por pares]Switzerland: Elsevier B.VTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
The potential of PSMA-targeted alpha therapy in the management of prostate cancerFilippi, Luca ; Chiaravalloti, Agostino ; Schillaci, Orazio ; Bagni, OresteExpert review of anticancer therapy, 2020-10, Vol.20 (10), p.823-829 [Periódico revisado por pares]England: Taylor & FrancisSem texto completo |
10 |
Material Type: Artigo
|
![]() |
Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapySraieb, Miriam ; Hirmas, Nader ; Conrad, Rupert ; Marinova, Milka ; Essler, Markus ; Herrmann, Ken ; Ahmadzadehfar, HojjatMedicine (Baltimore), 2020-09, Vol.99 (38), p.e22287 [Periódico revisado por pares]United States: Lippincott Williams & WilkinsTexto completo disponível |